Advancing Hydrocephalus Management: Pathogenesis Insights, Therapeutic Innovations, and Emerging Challenges

Hydrocephalus is a prevalent neurological disorder, particularly impactful in older adults, characterized by high incidence and numerous complications that impose a significant burden on healthcare systems. This review aims to provide a comprehensive description of hydrocephalus pathogenesis, focusi...

Full description

Saved in:
Bibliographic Details
Published inAging and disease
Main Authors Liu, Xiuyun, Zhi, Hui, Czosnyka, Marek, Robba, Chiara, Czosnyka, Zofia, Summers, Jennifer Lee, Yu, Huijie, Tong, Xiaoguang, Gao, Guoyi, Xiao, Gelei, Yu, Kai, Xing, Yan, Mao, Renling, Yin, Shaoya, Chao, Yangong, Li, Hongliang, Pu, Ke, Feng, Keke, Pang, Meijun, Ming, Dong
Format Journal Article
LanguageEnglish
Published United States 16.01.2025
Online AccessGet full text

Cover

Loading…
Abstract Hydrocephalus is a prevalent neurological disorder, particularly impactful in older adults, characterized by high incidence and numerous complications that impose a significant burden on healthcare systems. This review aims to provide a comprehensive description of hydrocephalus pathogenesis, focusing on cellular and molecular insights derived from animal models. We also present the latest advances in hydrocephalus research and highlight potential therapeutic targets. Lastly, the review advocates the integration of findings from both animal and human studies to achieve better outcomes and examines the potential of emerging technologies. We wish to raise public attention about this disease in an aging society. Current animal models for hydrocephalus involve acquired hydrocephalus models and genetic/congenital hydrocephalus models. Studies from animals have shown that the main mechanisms of models can be broadly classified into nine types. A variety of drug-targeted therapy methods and non-surgical treatment methods have been used in clinical practice. But current treatment approaches primarily focus on symptomatic relief and intracranial pressure control rather than addressing the underlying pathological mechanisms. We call for the development of more accurate and representative animal models to achieve better outcomes and examine the potential of emerging technologies, such as artificial intelligence and neuroimaging. In summary, this review synthesizes recent findings in hydrocephalus research, identifies promising therapeutic targets and interventions, and critically evaluates the limitations of current research paradigms, aiming to align preclinical studies with clinical endpoints. Continued studies and multidisciplinary collaboration are essential to develop effective interventions and facilitate new treatments into bedside.
AbstractList Hydrocephalus is a prevalent neurological disorder, particularly impactful in older adults, characterized by high incidence and numerous complications that impose a significant burden on healthcare systems. This review aims to provide a comprehensive description of hydrocephalus pathogenesis, focusing on cellular and molecular insights derived from animal models. We also present the latest advances in hydrocephalus research and highlight potential therapeutic targets. Lastly, the review advocates the integration of findings from both animal and human studies to achieve better outcomes and examines the potential of emerging technologies. We wish to raise public attention about this disease in an aging society. Current animal models for hydrocephalus involve acquired hydrocephalus models and genetic/congenital hydrocephalus models. Studies from animals have shown that the main mechanisms of models can be broadly classified into nine types. A variety of drug-targeted therapy methods and non-surgical treatment methods have been used in clinical practice. But current treatment approaches primarily focus on symptomatic relief and intracranial pressure control rather than addressing the underlying pathological mechanisms. We call for the development of more accurate and representative animal models to achieve better outcomes and examine the potential of emerging technologies, such as artificial intelligence and neuroimaging. In summary, this review synthesizes recent findings in hydrocephalus research, identifies promising therapeutic targets and interventions, and critically evaluates the limitations of current research paradigms, aiming to align preclinical studies with clinical endpoints. Continued studies and multidisciplinary collaboration are essential to develop effective interventions and facilitate new treatments into bedside.Hydrocephalus is a prevalent neurological disorder, particularly impactful in older adults, characterized by high incidence and numerous complications that impose a significant burden on healthcare systems. This review aims to provide a comprehensive description of hydrocephalus pathogenesis, focusing on cellular and molecular insights derived from animal models. We also present the latest advances in hydrocephalus research and highlight potential therapeutic targets. Lastly, the review advocates the integration of findings from both animal and human studies to achieve better outcomes and examines the potential of emerging technologies. We wish to raise public attention about this disease in an aging society. Current animal models for hydrocephalus involve acquired hydrocephalus models and genetic/congenital hydrocephalus models. Studies from animals have shown that the main mechanisms of models can be broadly classified into nine types. A variety of drug-targeted therapy methods and non-surgical treatment methods have been used in clinical practice. But current treatment approaches primarily focus on symptomatic relief and intracranial pressure control rather than addressing the underlying pathological mechanisms. We call for the development of more accurate and representative animal models to achieve better outcomes and examine the potential of emerging technologies, such as artificial intelligence and neuroimaging. In summary, this review synthesizes recent findings in hydrocephalus research, identifies promising therapeutic targets and interventions, and critically evaluates the limitations of current research paradigms, aiming to align preclinical studies with clinical endpoints. Continued studies and multidisciplinary collaboration are essential to develop effective interventions and facilitate new treatments into bedside.
Hydrocephalus is a prevalent neurological disorder, particularly impactful in older adults, characterized by high incidence and numerous complications that impose a significant burden on healthcare systems. This review aims to provide a comprehensive description of hydrocephalus pathogenesis, focusing on cellular and molecular insights derived from animal models. We also present the latest advances in hydrocephalus research and highlight potential therapeutic targets. Lastly, the review advocates the integration of findings from both animal and human studies to achieve better outcomes and examines the potential of emerging technologies. We wish to raise public attention about this disease in an aging society. Current animal models for hydrocephalus involve acquired hydrocephalus models and genetic/congenital hydrocephalus models. Studies from animals have shown that the main mechanisms of models can be broadly classified into nine types. A variety of drug-targeted therapy methods and non-surgical treatment methods have been used in clinical practice. But current treatment approaches primarily focus on symptomatic relief and intracranial pressure control rather than addressing the underlying pathological mechanisms. We call for the development of more accurate and representative animal models to achieve better outcomes and examine the potential of emerging technologies, such as artificial intelligence and neuroimaging. In summary, this review synthesizes recent findings in hydrocephalus research, identifies promising therapeutic targets and interventions, and critically evaluates the limitations of current research paradigms, aiming to align preclinical studies with clinical endpoints. Continued studies and multidisciplinary collaboration are essential to develop effective interventions and facilitate new treatments into bedside.
Author Czosnyka, Zofia
Xing, Yan
Ming, Dong
Xiao, Gelei
Chao, Yangong
Yu, Kai
Czosnyka, Marek
Yin, Shaoya
Mao, Renling
Yu, Huijie
Tong, Xiaoguang
Gao, Guoyi
Feng, Keke
Pang, Meijun
Liu, Xiuyun
Robba, Chiara
Zhi, Hui
Li, Hongliang
Summers, Jennifer Lee
Pu, Ke
Author_xml – sequence: 1
  givenname: Xiuyun
  surname: Liu
  fullname: Liu, Xiuyun
  organization: School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China
– sequence: 2
  givenname: Hui
  surname: Zhi
  fullname: Zhi, Hui
  organization: State Key Laboratory of Advanced Medical Materials and Devices, Medical School, Tianjin University, Tianjin, China
– sequence: 3
  givenname: Marek
  surname: Czosnyka
  fullname: Czosnyka, Marek
  organization: Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK
– sequence: 4
  givenname: Chiara
  surname: Robba
  fullname: Robba, Chiara
  organization: San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy
– sequence: 5
  givenname: Zofia
  surname: Czosnyka
  fullname: Czosnyka, Zofia
  organization: Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK
– sequence: 6
  givenname: Jennifer Lee
  surname: Summers
  fullname: Summers, Jennifer Lee
  organization: Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore 21287, USA
– sequence: 7
  givenname: Huijie
  surname: Yu
  fullname: Yu, Huijie
  organization: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
– sequence: 8
  givenname: Xiaoguang
  surname: Tong
  fullname: Tong, Xiaoguang
  organization: Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China
– sequence: 9
  givenname: Guoyi
  surname: Gao
  fullname: Gao, Guoyi
  organization: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
– sequence: 10
  givenname: Gelei
  surname: Xiao
  fullname: Xiao, Gelei
  organization: Medical School, Beijing Normal University, Beijing, China
– sequence: 11
  givenname: Kai
  surname: Yu
  fullname: Yu, Kai
  organization: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
– sequence: 12
  givenname: Yan
  surname: Xing
  fullname: Xing, Yan
  organization: Department of Neurology, Aviation General Hospital, Beijing, China
– sequence: 13
  givenname: Renling
  surname: Mao
  fullname: Mao, Renling
  organization: Department of Neurosurgery, Huadong Hospital, Fudan University, Shanghai, China
– sequence: 14
  givenname: Shaoya
  surname: Yin
  fullname: Yin, Shaoya
  organization: Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China
– sequence: 15
  givenname: Yangong
  surname: Chao
  fullname: Chao, Yangong
  organization: Department of Critical Care Medicine, The First Hospital of Tsing Hua University, Beijing, China
– sequence: 16
  givenname: Hongliang
  surname: Li
  fullname: Li, Hongliang
  organization: Department of Neurology, Aviation General Hospital, Beijing, China
– sequence: 17
  givenname: Ke
  surname: Pu
  fullname: Pu, Ke
  organization: Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China
– sequence: 18
  givenname: Keke
  surname: Feng
  fullname: Feng, Keke
  organization: Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China
– sequence: 19
  givenname: Meijun
  surname: Pang
  fullname: Pang, Meijun
  organization: Haihe Laboratory of Brain-Computer Interaction and Human-Machine Integration, Tianjin, China
– sequence: 20
  givenname: Dong
  surname: Ming
  fullname: Ming, Dong
  organization: Haihe Laboratory of Brain-Computer Interaction and Human-Machine Integration, Tianjin, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39908266$$D View this record in MEDLINE/PubMed
BookMark eNpNkU1PwkAQhjcGI4gcvZoePVjcr3ZbbwRQSDB64N5sd6cf2m5rtyXh39sKGucy8848eTOZuUYjUxlA6JbgOeGM-Y-L1ZxiygfFL9CEEo-6HvXw6F89RjNrP3AfLKQsZFdozMIQB9T3J-hzoQ_SqNykzuaom0pBncmis86rNDKFEkz75LzLNqtSMGBz62yNzdOstQ_OPoNG1tC1ueq7pjrINq9MP5BGO-sSmnSwXfZ-BZgU7A26TGRhYXbOU7R_Xu-XG3f39rJdLnauoiRoXWBc0H5TJkQsqGRSUUxUoH0ca08RrhNIfBUmnmKJFwQqjIkneKwJFlz6CZui-5Nt3VRfHdg2KnOroCikgaqzESM-C7gQxOvRuzPaxSXoqG7yUjbH6Pc-PeCeANVU1jaQ_CEERz8viBaraHjBoDj7BskEeKU
ContentType Journal Article
DBID AAYXX
CITATION
NPM
7X8
DOI 10.14336/AD.2024.1434
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2152-5250
ExternalDocumentID 39908266
10_14336_AD_2024_1434
Genre Journal Article
Review
GroupedDBID 53G
5VS
AAYXX
ABDBF
ACUHS
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
C1A
CITATION
DIK
EBD
ESX
GROUPED_DOAJ
HYE
IAO
IHR
IHW
ITC
KQ8
M~E
OK1
RPM
TUS
NPM
7X8
ID FETCH-LOGICAL-c218t-e3472923377b72a3ac201c8d60bd5c14dfef6c9f5c3f588c9b1574bd1074a6f3
ISSN 2152-5250
IngestDate Fri Jul 11 01:23:03 EDT 2025
Fri Feb 07 01:36:48 EST 2025
Tue Jul 01 04:25:10 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c218t-e3472923377b72a3ac201c8d60bd5c14dfef6c9f5c3f588c9b1574bd1074a6f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://doi.org/10.14336/ad.2024.1434
PMID 39908266
PQID 3163847715
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3163847715
pubmed_primary_39908266
crossref_primary_10_14336_AD_2024_1434
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-01-16
PublicationDateYYYYMMDD 2025-01-16
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-16
  day: 16
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Aging and disease
PublicationTitleAlternate Aging Dis
PublicationYear 2025
SSID ssj0000392393
Score 2.3413155
SecondaryResourceType review_article
Snippet Hydrocephalus is a prevalent neurological disorder, particularly impactful in older adults, characterized by high incidence and numerous complications that...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Title Advancing Hydrocephalus Management: Pathogenesis Insights, Therapeutic Innovations, and Emerging Challenges
URI https://www.ncbi.nlm.nih.gov/pubmed/39908266
https://www.proquest.com/docview/3163847715
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagXLgg2vJYKMhIqKcakthxUm5RW7RCAnFYpN4iPwsqZCuSPZRfz4wTJyktUuESbSytE_lzZr7xvAh57ayQsHk5k8YVTBitmNI2ZzZNuEq894nB846Pn-Tyi_hwmp9OnTxDdkmn35hfN-aV_A-qMAa4YpbsPyA7TgoD8BvwhSsgDNdbYRxaIhs09peXFjXRxVf1fdPOYlrQ4P8MJG99hjLtW4vBAWiOD8FBY-4VjMfuqG0M6MTzqtDC6Cg2XGnnVLY6i_mNcyfPcICQYawe6_MbezmDnW0Zejd7lXB97JqUFTz0gamOwb7OBN6LSZ1EF_ofWmaM_UOrAyeoq-Ma_4534i65lwHPn9vEQZUCe-OhcPL4QkOdVJzh7fwFrvKKvxgLgTSsHpIHA9unVQ_dNrnjmh2yWzWqW_-4pPs0xN8Gx8YuOR_RpFfQpBOa7-gcSxqxPKAzJOkMyQMK8NCII51wfERW709WR0s2tMJgBjhYxxwXYAVlnBeFLjLFsbBmakorE_iwTCqsd16aQ58b7vOyNIc6zQuhLYbbKun5Y7LVrBv3lFDLXZmU3nKBlQ9BfPOs9FIrmahUJ14syH5cx_qiL3hS3wjZgryKq1yDSEI_k2rcetPWHDm-KIo0X5An_fKPUwEfBtIp5bPbPuY5uT9t2j2y1f3cuBfAAzv9MuyV33rMXAY
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advancing+Hydrocephalus+Management%3A+Pathogenesis+Insights%2C+Therapeutic+Innovations%2C+and+Emerging+Challenges&rft.jtitle=Aging+and+disease&rft.date=2025-01-16&rft.issn=2152-5250&rft.eissn=2152-5250&rft_id=info:doi/10.14336%2FAD.2024.1434&rft.externalDBID=n%2Fa&rft.externalDocID=10_14336_AD_2024_1434
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2152-5250&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2152-5250&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2152-5250&client=summon